Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12617001316392
ACTRN12617001316392
Completed
N/A

A phase 1 pre-post intervention trial with 12 week baseline control determining the merits of a lower limb robotic exoskeleton (HELLEN) in the rehabilitation of Multiple Sclerosis (MS).

niversity of Newcastle0 sites10 target enrollmentSeptember 13, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmultiple sclerosisNeurological - Multiple sclerosisPhysical Medicine / Rehabilitation - Physiotherapy

Overview

Phase
N/A
Intervention
Not specified
Conditions
multiple sclerosis
Sponsor
niversity of Newcastle
Enrollment
10
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2017
End Date
March 11, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Newcastle

Eligibility Criteria

Inclusion Criteria

  • •1\. Diagnosis of MS
  • •2\. Resident of the Hunter region over the age of 18 years
  • •3\. Severe mobility impairment whereby the participant is reliant on a mobility aid or other people for upright activities (Scores \>6 on the Expanded Disability Status Scale)

Exclusion Criteria

  • •1\. Weight \>100kg or \<40kg; height \>6'4 or \<4'8 (criteria set by the REX Bionics)
  • •2\. Pregnancy
  • •3\. Unstable or severe cardiac or respiratory conditions
  • •4\. Recent fractures in lower limbs/pelvis/spine
  • •5\. Significant cognitive impairment (\<19 on MoCA)
  • •6\. Any medical condition which limits the ability to exercise in an upright position

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Can Enhanced Recovery After Surgery (ERAS) principles be implemented in an Australian healthcare setting to improve patient recovery after total hip replacement (THR)?total hip replacementtotal hip arthroplastyanaesthesiarecovery after anaesthesiaperioperative medicinepostoperative analgesiaAnaesthesiology - AnaestheticsAnaesthesiology - Pain managementMusculoskeletal - Osteoarthritis
ACTRN12615001170516icole Tan230
Completed
N/A
Prevention of type 2 diabetes mellitus through educational intervention for adolescents at risk in high schools in JordaOverweight or obese adolescents at high risk for type 2 diabetes mellitusNutritional, Metabolic, EndocrineDiabetes mellitus
ISRCTN38144270Al -Zaytoonah University (Jordan)400
Recruiting
Phase 4
A clinical trial to evaluate aflibercept treatment in patients with diabetic macular edema.Health Condition 1: H353- Degeneration of macula and posterior pole
CTRI/2022/08/044792Bayer Zydus Pharma Private Limited
Active, Not Recruiting
Phase 1
A 12-month prospective, randomized, interventional, global, multi-center, active-controlled study comparing sustained benefit of two treatment paradigms in adult episodic migraine patientsMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraine preventionTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2018-001228-20-DEovartis Pharma AG600
Active, Not Recruiting
Phase 1
A 12-month prospective, randomized, interventional, global, multi-center, active-controlled study comparing sustained benefit of two treatment paradigms in adult episodic migraine patientsMigraine preventionMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2018-001228-20-PTovartis Pharma AG621